CareTrust REIT, Inc. (CTRE)

In the past six months, CareTrust REIT reported strong financial results for Q3 2025, with net income jumping 67% year-over-year and normalized Funds From Operations (FFO) reaching $94.7 million. The stock price has shown positive momentum, gaining 0.596% on February 6, 2026, and rising 5.4% over the two weeks prior, hitting an all-time high of $38.36 USD on February 5, 2026. CareTrust REIT announced a quarterly dividend of $0.335 per share on December 16, 2025, and acquired six skilled nursing facilities in the Mid-Atlantic region for approximately $142 million, effective January 1, 2026. Analyst sentiment has been positive, with BMO Capital upgrading the company's rating to Outperform and raising its price target to $43.00, and Citizens initiating coverage with a Market Outperform rating and a $44.00 price target. Additionally, short interest in CareTrust REIT decreased by 9.74%, suggesting improving investor sentiment. The company also announced key promotions and new hires, including Derek Bunker as Chief Financial Officer, and amended its partnership agreement to introduce new LTIP units. CareTrust REIT is expected to release its next earnings report on February 12, 2026.

The demand for CareTrust REIT's underlying products and services is primarily driven by long-term demographic trends rather than short-term seasonal fluctuations. The aging population and the increasing prevalence of conditions like dementia contribute to a stable and rising demand for care homes. This suggests a consistent, rather than seasonal, demand for the types of properties CareTrust REIT invests in.

CareTrust REIT, Inc. is a self-administered real estate investment trust (REIT) focused on healthcare-related properties. It operates in the Healthcare REIT sector, specializing in senior housing and skilled nursing industries, acquiring and leasing properties to healthcare operators under long-term, triple-net leases. The company also generates income by providing financing to its operators.

CareTrust REIT's real estate portfolio spans across the United States and the United Kingdom. As of September 30, 2025, the company owned 390 net-leased healthcare properties across 31 U.S. states and the United Kingdom, encompassing 35,687 operating beds/units. The company has concentrations in the western United States, particularly in Texas and California, and also holds assets in key states such as Florida, Michigan, and Ohio.

CareTrust REIT has maintained a positive brand reputation over the past year. The company's news sentiment score is 1.15, indicating generally positive media coverage, and analysts have a consensus "Buy" or "Moderate Buy" rating for the stock. InvestingPro has given CareTrust REIT an "GREAT" overall financial health score. In Q4 2024, S&P Global Ratings upgraded CareTrust's corporate rating to BB+ and its unsecured notes to BBB-, reflecting improved creditworthiness.

CareTrust REIT, Inc. is predominantly owned by institutional investors, who control approximately 99.16% to 99.75% of the company's shares. Major institutional shareholders include BlackRock, Inc., Vanguard Group Inc, Cohen & Steers, Inc., State Street Corp, Fmr Llc, Wellington Management Group Llp, Geode Capital Management, Llc, Charles Schwab Investment Management, Inc., T. Rowe Price Group, Inc., and Daiwa Asset Management Co., Ltd. Individual and insider ownership accounts for a smaller portion, around 0.25% to 0.80% of the shares, with the CEO holding 0.2%.